Savara Inc. (SVRA)
NASDAQ·Healthcare·Biotechnology
$5.07
-1.84%
Mkt Cap $1.01B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | — | — | — | -$0.12 | -$0.13 | -8.33% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.13 | -$0.14 | -7.69% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.12 | -$0.14 | -16.67% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.12 | -$0.12 | +0.00% | — | — |
| Q1 2025 Mar 27, 2025 | — | $272.00K | — | -$0.11 | -$0.13 | -18.18% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.11 | -$0.11 | +0.00% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.11 | -$0.12 | -9.09% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.10 | -$0.11 | -10.00% | — | — |
| Q1 2024 Mar 7, 2024 | — | — | — | -$0.11 | -$0.09 | +18.18% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.07 | -$0.10 | -42.86% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.08 | -$0.07 | +12.50% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.07 | -$0.07 | +0.00% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.08 | -$0.07 | +12.50% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.07 | -$0.07 | +0.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.08 | -$0.05 | +37.50% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$0.07 | -$0.07 | +0.00% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.09 | -$0.07 | +22.22% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.12 | -$0.07 | +41.67% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.08 | -$0.13 | -62.50% | — | — |